Tiziana Vavalà

<i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer

Kartik Konduri, Jean‐Nicolas Gallant, Young Kwang Chae et al. · Cancer Discovery · 2016 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of<i>EGFR</i>mutant advanced lung adenocarcinoma

Emilio Bria, Sara Pilotto, Eliana Amato et al. · Oncotarget · 2015 · 86 citations · Full text

Medicine, Molecular Biology, Oncology +17

ATF2 contributes to cisplatin resistance in non‐small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway

Marco Lo Iacono, Valentina Monica, Tiziana Vavalà et al. · International Journal of Cancer · 2014 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Sara Pilotto, Antônio Rossi, Tiziana Vavalà et al. · Clinical Lung Cancer · 2017 · 46 citations

Medicine, Oncology, Molecular Oncology +9

Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice—A new approach to improve personalized translational research

Tiziana Vavalà, Valentina Monica, Marco Lo Iacono et al. · Lung Cancer · 2016 · 39 citations · Full text

Medicine, Molecular Medicine, Oncology +17